Bureau Veritas (fka Maxxam) is the provider of ChemoAlert™ - the complete USP<800> hazardous drug surface residual solution for safeguarding patient and clinician safety. A comprehensive/simple sampling kit which can assess up to 19 drugs from a single swab using the most sensitive and specific technology available. Fully validated, empirically verified, and analyzed by an AIHA accredited lab.